![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Sickle Cell Disease - What Is Sickle Cell Disease? - NHLBI, NIH
2024年9月30日 · Sickle cell disease affects more than 100,000 people in the United States and 8 million people worldwide. In the United States, 9 of 10 people who have sickle cell disease are of African ancestry or identify as Black: About 1 in 13 Black babies are born with sickle cell trait,meaning that they inherited a sickle cell gene from one parent.
Sickle Cell Disease - Living With Sickle Cell Disease - NHLBI, NIH
2024年8月22日 · Most people who have sickle cell disease should see their provider every 3 to 12 months, depending on their age and the type of sickle cell disease they have. Get regular vaccines, including an influenza (flu) shot every year, and the COVID-19 vaccine as recommended. Routine vaccines, such as those for pneumonia and meningococcal disease, …
Reducing the Burden of Sickle Cell Disease | NHLBI, NIH
2011年8月1日 · Her life, like that of many others with sickle cell disease, has been immeasurably improved because of research supported by the National Institutes of Health (NIH). Sickle cell disease is an inherited condition that affects the ability of red blood cells to travel throughout the body, and shortens the lifespan of the cells.
How Sickle Cell Disease May Affect Your Health - NHLBI, NIH
2024年8月22日 · People who have sickle cell disease usually also have mild to moderate anemia. At times, they can have severe anemia. Severe anemia can be life-threatening. Severe anemia in a newborn or child who has sickle cell disease may be a result of one of two conditions:
Sickle Cell Disease Fact Sheet - NHLBI, NIH
Ordering More Copies To request quantities of publications greater than the copy limit, please contact the NHLBI Center for Health Information between 8:30 a.m. and 5 p.m. eastern time, Monday through Friday, by telephone at 1-877-NHLBI4U (1-877-645-2448) or email at [email protected].
Sickle Cell Disease - Treatment - NHLBI, NIH
2024年9月30日 · Hydroxyurea is an oral medicine that is frequently prescribed to help treat sickle cell disease. Hydroxyurea is an oral medicine that can reduce sickling of red blood cells and help prevent serious symptoms of sickle cell disease, including pain crises. Healthcare providers usually prescribe daily hydroxyurea for infants as young as 9 months ...
Sickle Cell Disease Research & Care - NHLBI, NIH
2012年4月12日 · In the 1970s, life expectancy for individuals with sickle cell disease was about 14 years. Today, many individuals live into their 40s and longer. FDA approval in the 1990s of the drug hydroxyurea to treat adults with the disease was a major advance.
Sickle cell disease is a lifelong illness and can harm a person’s spleen, brain, eyes, lungs, liver, heart, kidneys, penis, joints, bones, or skin. The severity of the disease varies widely from person to person. In the early 1970s, the average life span …
The sky’s the limit: Woman with sickle cell disease gets life …
2016年6月16日 · Thanks to advances in treatment, though, the life expectancy for Americans with sickle cell disease has dramatically increased over the last decades—from about 14 years in the 1970s to 40 to 50 years, and longer, today. Still, a widely-available cure remains elusive.
Sickle Cell Disease - Sickle Cell Trait - NHLBI, NIH
2024年8月22日 · Sickle cell trait occurs when a person has one copy of the sickle cell gene passed down from one parent along with a normal hemoglobin gene (hemoglobin A) from the other parent. People who have sickle cell trait are sometimes called carriers . Sickle cell trait is different from sickle cell anemia or sickle cell disease.